New Echocardiographic Methods for Right Ventricular Function.
NEW-RV
Evaluation of New Echocardiographic Methods for Measurement of Right Ventricular Function.
1 other identifier
observational
150
1 country
1
Brief Summary
Aims of this study are the evaluation of new echocardiographic methods (3D/4D- and strain-echocardiography) for measurement of the right ventricular (RV) function .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 28, 2010
CompletedFirst Posted
Study publicly available on registry
October 29, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedNovember 8, 2016
November 1, 2016
5.2 years
October 28, 2010
November 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
3D-volumetry of the right ventricle
2 years
2D strain of the right ventricle
2 years
Secondary Outcomes (5)
pulmonary artery systolic pressure (PASP)
2 years
tricuspid annular plane systolic excursion (TAPSE)
2 years
tricuspid annular systolic velocity (TASV)
2 years
Tei-index (myocardial performance index)
2 years
LV-eccentricity-index (Lei-index)
2 years
Study Arms (3)
control
participants without structural heart disease
CHF
patients with chronic heart failure of the left ventricle affecting the right heart
PAH
patients with pulmonary arterial hypertension without left ventricular dysfunction
Eligibility Criteria
* patients with pulmonary aterial hypertension * patients with chronic heart failure of the left ventricle affecting the right heart * patients without structural heart disease who underwent an echocardiographic examination for other reasons (control group)
You may qualify if:
- persons of 18 years and older who receive a transthoracic echocardiography at our department
- written consent
You may not qualify if:
- present atrial fibrillation/flutter
- permanent pacemaker rhythm
- moderate/severe valvular heart disease
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Heidelberg
Heidelberg, Baden-Wurttemberg, 69120, Germany
Related Publications (3)
Greiner S, Andre F, Heimisch M, Hess A, Steen H, Katus HA, Mereles D. Non-invasive quantification of right ventricular systolic function by echocardiography: a new semi-automated approach. Clin Res Cardiol. 2013 Mar;102(3):229-35. doi: 10.1007/s00392-012-0528-z. Epub 2012 Dec 4.
PMID: 23208080RESULTGreiner S, Goppelt F, Aurich M, Katus HA, Mereles D. Prognostic relevance of the right ventricular myo-mechanical index (RV-MMI) in patients with precapillary pulmonary hypertension. Open Heart. 2018 Sep 12;5(2):e000903. doi: 10.1136/openhrt-2018-000903. eCollection 2018.
PMID: 30245839DERIVEDGreiner S, Heimisch M, Aurich M, Hess JA, Katus HA, Mereles D. Multiplane two-dimensional strain echocardiography for segmental analysis of right ventricular mechanics: new-RV study. Clin Res Cardiol. 2014 Oct;103(10):817-24. doi: 10.1007/s00392-014-0723-1. Epub 2014 May 16.
PMID: 24830514DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sebastian Greiner, M.D.
Heidelberg University
- PRINCIPAL INVESTIGATOR
Derliz Mereles, M.D.
Heidelberg University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Derliz Mereles, M.D.
Study Record Dates
First Submitted
October 28, 2010
First Posted
October 29, 2010
Study Start
October 1, 2010
Primary Completion
December 1, 2015
Last Updated
November 8, 2016
Record last verified: 2016-11